Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies (Q33364359)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies |
scientific article |
Statements
1 reference
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies (English)
1 reference
Robert Z Orlowski
1 reference
E Claire Dees
1 reference
Reynaldo A Garcia
1 reference
Celeste M Lindley
1 reference
Peter M Voorhees
1 reference
Melissa D Hall
1 reference
Fred J Kudrik
1 reference
Tammy Allred
1 reference
Anandhi R Johri
1 reference
Paul E Jones
1 reference
Anastasia Ivanova
1 reference
Hendrik W Van Deventer
1 reference
Don A Gabriel
1 reference
Thomas C Shea
1 reference
Beverly S Mitchell
1 reference
Julian Adams
1 reference
Dixie-Lee Esseltine
1 reference
Elizabeth G Trehu
1 reference
Marie Green
1 reference
Mary Jo Lehman
1 reference
Susan Natoli
1 reference
Jason M Collins
1 reference
30 December 2004
1 reference
1 reference
105
1 reference
3058-3065
1 reference
Identifiers
1 reference
1 reference